258 related articles for article (PubMed ID: 12777317)
1. Fibrinolysis for acute myocardial infarction: the future is here and now.
Armstrong PW; Collen D; Antman E
Circulation; 2003 May; 107(20):2533-7. PubMed ID: 12777317
[No Abstract] [Full Text] [Related]
2. Fibrinolytic therapy: is it a treatment of the past?
Grines CL; Serruys P; O'Neill WW
Circulation; 2003 May; 107(20):2538-42. PubMed ID: 12777318
[No Abstract] [Full Text] [Related]
3. [Pharmacologic reperfusion in acute myocardial infarction].
Martínez Sánchez C
Arch Cardiol Mex; 2001; 71 Suppl 1():S131-5. PubMed ID: 11565318
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V.
Ferreira D
Rev Port Cardiol; 2003; 22(7-8):1005-9. PubMed ID: 14587168
[No Abstract] [Full Text] [Related]
5. [Strategies to improve reperfusion with fibrinolytic therapy in ST-T elevation myocardial infarction].
Jerjes-Sánchez C; Sosa del Angel E; García Sosa A; Reyes Cerezo E; Garza Ruiz A
Arch Cardiol Mex; 2003; 73(1):46-58. PubMed ID: 12820494
[TBL] [Abstract][Full Text] [Related]
6. Overview of contemporary reperfusion strategies in acute ST-elevation myocardial infarction.
Haude M; Schulz R; Heusch G; Erbel R
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):667-80. PubMed ID: 16076277
[TBL] [Abstract][Full Text] [Related]
7. Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction.
Antman EM; Van de Werf F
Circulation; 2004 Jun; 109(21):2480-6. PubMed ID: 15173037
[No Abstract] [Full Text] [Related]
8. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
Kandzari DE
Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
[TBL] [Abstract][Full Text] [Related]
9. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
Antman EM; Morrow DA; McCabe CH; Jiang F; White HD; Fox KA; Sharma D; Chew P; Braunwald E;
Am Heart J; 2005 Feb; 149(2):217-26. PubMed ID: 15846258
[No Abstract] [Full Text] [Related]
10. Fibrinolytic agents for the management of ST-segment elevation myocardial infarction.
Hilleman DE; Tsikouris JP; Seals AA; Marmur JD
Pharmacotherapy; 2007 Nov; 27(11):1558-70. PubMed ID: 17963464
[TBL] [Abstract][Full Text] [Related]
11. Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options.
Boden WE; Eagle K; Granger CB
J Am Coll Cardiol; 2007 Sep; 50(10):917-29. PubMed ID: 17765117
[TBL] [Abstract][Full Text] [Related]
12. ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis.
Gabriel RS; White HD
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):851-7. PubMed ID: 17867915
[TBL] [Abstract][Full Text] [Related]
13. Current status of antithrombotic agents in acute myocardial infarction.
Khalilullah M; Sathyamurthy I
J Assoc Physicians India; 1981 May; 29(5):351-7. PubMed ID: 7028713
[No Abstract] [Full Text] [Related]
14. [Reperfusion in acute ST-elevation infarction: Fibrinolysis prior to elective PCI impairs the result!].
Eriksson P
Lakartidningen; 2006 Jul 12-25; 103(28-29):2126-7. PubMed ID: 16895094
[No Abstract] [Full Text] [Related]
15. A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study.
Scirica BM; Morrow DA; Sadowski Z; Ruda M; Nicolau JC; Giugliano RP; Wiviott SD; Sabatine MS; Shui A; Antman EM; Braunwald E
Eur Heart J; 2007 Sep; 28(17):2070-6. PubMed ID: 17600039
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1.
Armstrong PW; Collen D
Circulation; 2001 Jun; 103(23):2862-6. PubMed ID: 11401946
[No Abstract] [Full Text] [Related]
17. [Bolus fibrinolysis in acute myocardial infarction].
Zeymer U
Dtsch Med Wochenschr; 2002 Oct; 127(40):2083-6. PubMed ID: 12373644
[No Abstract] [Full Text] [Related]
18. [Anticoagulant therapy in acute myocardial infarct. Therapeutic indications based on incomplete experimental data].
Goldman L
Recenti Prog Med; 1980 Apr; 68(4):382-93. PubMed ID: 6992245
[No Abstract] [Full Text] [Related]
19. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
[TBL] [Abstract][Full Text] [Related]
20. Single lead ST-segment recovery: a simple, reliable measure of successful fibrinolysis after acute myocardial infarction.
Syed MA; Borzak S; Asfour A; Gunda M; Obeidat O; Murphy SA; Gibbons RJ; Gourlay SG; Barron HV; Weaver WD; Hudson M
Am Heart J; 2004 Feb; 147(2):275-80. PubMed ID: 14760325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
